Miller Place, NY, United States of America

Arati Deshpande

This inventor holds 3 USPTO granted patents. Top assignee: Par Pharmaceutical, Inc.. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arati Deshpande. Retrieved from https://idiyas.com/inventor/arati-deshpande

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Biography of Inventor Arati Deshpande

Introduction: Arati Deshpande is an accomplished inventor based in Miller Place, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative nasal calcitonin formulations.

Latest Patents: Arati holds three patents, with her latest focusing on nasal calcitonin formulations containing chlorobutanol. This aqueous solution of calcitonin is designed for intranasal administration and comprises calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water. The solution has a pH of less than 4 and is free from benzalkonium chloride. It is intended for the treatment of osteoporosis, Paget's bone disease, and hypercalcemia.

Career Highlights: Arati is currently employed at Par Pharmaceutical, Inc., where she continues to innovate in the pharmaceutical industry. Her work has been instrumental in advancing treatment options for various bone-related conditions.

Collaborations: Throughout her career, Arati has collaborated with notable professionals in her field, including Steven C Quay and Jorge C De Meireles. These collaborations have further enhanced her research and development efforts.

Conclusion: Arati Deshpande's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her dedication to improving healthcare solutions. Her work continues to

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…